Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydraulic Tissue Resistance at Subcutaneous Insulin Infusion Sites in Type 1 Diabetes
2015-005311-32Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin aspart in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Medical University of Graz. Primary endpoint: Specific tissue resistance (sTR) at infusion sites. Started Dec 2015; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2015-005311-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005311-32.